Synple Chem acquired by eMolecules
25.09.2024
The combination strengthens eMolecules’ position as the global one-stop-shop solution provider for efficient chemical compound procurement, full-service compound management, and automation solutions for drug discovery researchers.
 Synple Chem's Co-Founders: CCO Paula Nichols and CEO Benedikt Wanner
|
 |
eMolecules, provider of the industry-leading chemical compound search-and-fulfilment platform for early discovery chemistry research, today announced that it has acquired Synple Chem.
Synple specializes in automated chemical synthesis systems and solutions for small molecule drug discovery customers. With Synple’s virtual compound library, which provides access to more than 7 trillion tractable compounds, combined with eMolecules’ eXplore library of more than 4 trillion compounds, eMolecules now offers the world’s most diverse selection of virtual compounds.
Headquartered near Zurich, Synple serves premier pharma and biotech customers in the United States and Europe. The acquisition strategically expands eMolecules’ product and service portfolio to include automation solutions and enhances its one-stop-shop offering for drug discovery customers.
Researchers can quickly and efficiently search for and obtain compounds from hundreds of speciality chemical suppliers with over 100 million in-stock SKUs. They can simultaneously search across their proprietary libraries and trillions of virtual compounds via eMolecules’ and Synple’s virtual libraries.
Synple Chem was ranked among the TOP 100 Swiss Startups in 2017 and 2020 and won Venture Kick in 2016.
Synple Chem team
Synple specializes in automated chemical synthesis systems and solutions for small molecule drug discovery customers. With Synple’s virtual compound library, which provides access to more than 7 trillion tractable compounds, combined with eMolecules’ eXplore library of more than 4 trillion compounds, eMolecules now offers the world’s most diverse selection of virtual compounds.
Headquartered near Zurich, Synple serves premier pharma and biotech customers in the United States and Europe. The acquisition strategically expands eMolecules’ product and service portfolio to include automation solutions and enhances its one-stop-shop offering for drug discovery customers.
Researchers can quickly and efficiently search for and obtain compounds from hundreds of speciality chemical suppliers with over 100 million in-stock SKUs. They can simultaneously search across their proprietary libraries and trillions of virtual compounds via eMolecules’ and Synple’s virtual libraries.
Synple Chem was ranked among the TOP 100 Swiss Startups in 2017 and 2020 and won Venture Kick in 2016.
Synple Chem team